Clinical Trial Update: Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes the termination of a randomized Velcade-based regimen with autologous stem cell transplantation in newly diagnosed multiple mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: TERMINATED